Long-Term Outcomes in Patients with Not-Retrieval Inferior Vena Cava Filter Under Anticoagulation

Sakai, Ryohei; Fujiki, Shinya; Kashimura, Takeshi; Tsuchiya, Hiroki; Takahashi, K.; Ozaki, Kazuyuki; Okura, Yuji; Hanzawa, Kazuhiko; Inomata, Takayuki

doi:10.1536/ihj.21-814

Cited by 2 publications

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Sakai R et al reported 6 symptomatic DVT recurrences and 13 bleeding events in 158 patients with non-retrieval IVC filters within a mean follow-up of 5 years. 38 However, on rivaroxaban, the risk of major bleeding is lower than on VKA. 15 In the study of Wang B et al, the only major gastrointestinal bleeding was reported on rivaroxaban, while in the current study it was not observed.…”

Section: Discussionmentioning

confidence: 99%

Oral Rivaroxaban Versus Warfarin After inferior Vena cava Filter Implantation: A Retrospective Cohort Study

Schastlivtsev,

Pankov,

Tsaplin

et al. 2024

Clin Appl Thromb Hemost

View full text Add to dashboard Cite

Objectives To assess the efficacy and safety of rivaroxaban compared to warfarin after inferior vena cava (IVC) filter implantation. Method This retrospective analysis includes data from 100 patients with deep vein thrombosis (DVT) who underwent IVC filter implantation due to a free-floating thrombus (n = 64), thrombus propagation (n = 8), or acute bleeding (n = 8) on therapeutic anticoagulation, catheter-directed thrombolysis (n = 8), or had previously implanted filter with DVT recurrence. Patients were treated with warfarin (n = 41) or rivaroxaban (n = 59) for 3-12 months. Symptomatic venous thromboembolism (VTE) recurrence and bleeding events were assessed at 12 months follow-up. Results Three (7.3%) cases of VTE recurrence without IVC filter occlusion occurred on warfarin and none on rivaroxaban. The only (2.4%) major bleeding occurred on warfarin. Three (5.1%) clinically relevant non-major bleedings were detected on rivaroxaban. No significant differences existed between groups when full and propensity scores matched datasets were compared. Conclusions Rivaroxaban seems not less effective and safe than warfarin after IVC filter implantation.

show abstract

Section: Discussionmentioning

confidence: 99%